플러스100%마이너스

통합검색
닫기

KMCRIC 챗봇에게

질문하기!

한의약융합데이터센터


근거중심한의약 DB

Home > 한의약융합데이터센터 > 근거중심한의약 DB
Title

Acupuncture therapy for radiotherapy-induced adverse effect: A systematic review and network meta-analysis.

Authors

Wu T, Fu C, Deng Y, Huang W, Wang J, Jiao Y.

Journal

Front Public Health.

Year

2022

Vol (Issue)

10

Page

1026971.

doi

10.3389/fpubh.2022.1026971.

PMID

36590000

Url

http://www.ncbi.nlm.nih.gov/pubmed/36590000

MeSH

Acupuncture Therapy*
Humans
Network Meta-Analysis
Radiation Injuries* / etiology
Radiation Injuries* / therapy
Radiotherapy / adverse effects

Keywords

acupuncture therapy; adverse effect; network meta-analysis; radiotherapy; systematic review

한글 키워드

KMCRIC summary and commentary

없음

Korean Study

N

Abstract

Objective: To evaluate the efficacy of different acupuncture therapies for radiotherapy-induced adverse effects (RIAEs) and find out the optimal scheme.

Methods: Eligible randomized controlled trials (RCTs) were collected from inception to June 2020 from 9 bibliographic databases. The risk of bias evaluation of the analyzed literature was carried out using the Cochrane risk-of-bias tool. Network meta-analysis was mainly performed using STATA 14.2 and OpenBUGS 3.2.3 by figuring out the network diagrams, league figures, and SUCRA values.

Results: A total of 41 studies with 3,011 participants reported data suitable for network meta-analysis. There was a low to moderate risk of bias in twenty of the articles. ST36 was the most widely prescribed acupoint. Based on network meta-analysis, four outcome indicators were described, namely, acupuncture + medication ranked first in treating radiation enteritis, moxibustion + medication ranked first in preventing radiotherapy-induced leukopenia, acupuncture + medication ranked first in preventing radioactive oral mucositis, and acupuncture ranked first in improving the stimulated salivary flow rate of radioactive xerostomia.

Conclusion: The findings of the network meta-analysis manifested that acupuncture therapy combined with medication has superiority in most RIAEs, both reducing incidence and relieving symptoms. However, high-quality studies are still needed to provide conclusive evidence.

Systematic review registration: https://inplasy.com/inplasy-2020-7-0054/, identifier: INPLASY202070054.

국문초록

N

Language

영어

첨부파일